IMI Launches EUR 130 Million Calls for Proposals with Focus on Alzheimer's Disease, Big Data, Vaccines, and More
The Innovative Medicines Initiative (IMI) is launching two new Calls for proposals with topics on Alzheimer's disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results. The total budget for the two Calls stands at just over EUR 130 million.
Read more ...
IMI Launches New Antimicrobial Resistance Accelerator Programme as Part of Latest Calls for Proposals
A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched today by the Innovative Medicines Initiative (IMI). Of the other topics launched in the Calls, many address brain disorders (e.g. Alzheimer's disease, Parkinson's disease, Huntington's disease, major depression) and immune-mediated diseases (e.g. rheumatoid arthritis and lupus as well as inflammatory bowel diseases such as Crohn's and colitis, and skin diseases like dermatitis and psoriasis).
Read more ...
NATO Programme for Security Through Science
The Security Through Science Programme offers grants to scientists in NATO, Partner and Mediterranean Dialogue countries to collaborate on priority research topics.
Read more ...
Open Access Drug Development Tools Feature in New IMI Call for Proposals
New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of the Call is over EUR 80 million. Half of this comes from the European Commission's Horizon 2020 programme and will fund the participation in the projects of universities, small and medium-sized companies, patient groups etc.
Read more ...
Open Call CEF-TC 2015-2: CEF Telecom Call - eHealth
2015 CEF-TC 2015-2 call aims to support the deployment of generic services by Member States, namely in the areas of Patient Summary and ePrescription/eDispensation, as defined in the relevant guidelines and documents adopted by the eHealth Network and in coherence with the core services in order to allow EU-wide interoperability.
Read more ...
Open Call DIGITAL-2021-DEPLOY-01-HEALTH: Uptake of Digital Solutions in Health and Care
The consolidation of a European framework and ecosystem of digital health solutions and services, covering technological and organisational innovation and addressing the needs of the involved stakeholders, including those of SMEs and start-ups.
Read more ...
Open Call DIGITAL-2021-DEPLOY-01-TWINS-HEALTH: An Ecosystem for Digital Twins in Healthcare
The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches, faster and more accurate diagnoses, personalised treatments and care, a framework to structure cooperation and leverage on synergies between academia, private sector, regulators and end-users needs to be strengthened.
Read more ...
The Innovative Medicines Initiative (IMI) is launching two new Calls for proposals with topics on Alzheimer's disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results. The total budget for the two Calls stands at just over EUR 130 million. 
The Security Through Science Programme offers grants to scientists in NATO, Partner and Mediterranean Dialogue countries to collaborate on priority research topics. 
2015 CEF-TC 2015-2 call aims to support the deployment of generic services by Member States, namely in the areas of Patient Summary and ePrescription/eDispensation, as defined in the relevant guidelines and documents adopted by the eHealth Network and in coherence with the core services in order to allow EU-wide interoperability. 
The consolidation of a European framework and ecosystem of digital health solutions and services, covering technological and organisational innovation and addressing the needs of the involved stakeholders, including those of SMEs and start-ups.